Brief: Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market To Nasdaq Global Select Market
03/03/2026 11:26
March 3 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O: TONIX PHARMACEUTICALS ANNOUNCES UPLISTING FROM NASDAQ CAPITAL MARKET TO NASDAQ GLOBAL SELECT MARKET TONIX PHARMACEUTICALS - RECEIVED APPROVAL FROM NASDAQ TO TRANSFER LISTING FROM NASDAQ CAPITAL MARKET TO THE NASDAQ GLOBAL SELECT MARKET TONIX PHARMACEUTICALS - TRADING ON NASDAQ GLOBAL SELECT MARKET EXPECTED TO COMMENCE ON MARCH 3, UNDER COMPANY’S EXISTING TICKER SYMBOL “TNXP” Source text: ID:nGNX8JtNNY Further company coverage: TNXP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tonix Pharmaceuticals Holding
See all newsBrief: Tonix Pharmaceuticals Secures Second Commercial Payer Agreement For Tonmya®, Expanding Total Commercial Coverage To ~52 Million U.S. Lives
Tonix Pharmaceuticals Q1 net loss widens on higher SG&A expenses
Brief: Tonix Pharmaceuticals Announces Presentations At World Vaccine Congress Washington 2026
Tonix Pharmaceuticals Q4 revenue more than doubles, net loss widens
Brief: Tonix Pharmaceuticals Announces Uplisting From Nasdaq Capital Market To Nasdaq Global Select Market